Your browser doesn't support javascript.
loading
Switching from natalizumab to ocrelizumab in patients with multiple sclerosis.
Levin, Seth N; Ezuma, Chimere; Levine, Libby; Vargas, Wendy S; Farber, Rebecca S; De Jager, Philip L; Riley, Claire S.
Afiliação
  • Levin SN; Department of Neurology and Multiple Sclerosis Center, Columbia University Irving Medical Center, New York, NY, USA.
  • Ezuma C; Department of Neurology and Multiple Sclerosis Center, Columbia University Irving Medical Center, New York, NY, USA.
  • Levine L; Department of Neurology and Multiple Sclerosis Center, Columbia University Irving Medical Center, New York, NY, USA.
  • Vargas WS; Department of Neurology and Multiple Sclerosis Center, Columbia University Irving Medical Center, New York, NY, USA.
  • Farber RS; Department of Neurology and Multiple Sclerosis Center, Columbia University Irving Medical Center, New York, NY, USA.
  • De Jager PL; Department of Neurology and Multiple Sclerosis Center, Columbia University Irving Medical Center, New York, NY, USA.
  • Riley CS; Department of Neurology and Multiple Sclerosis Center, Columbia University Irving Medical Center, New York, NY, USA.
Mult Scler ; 26(14): 1964-1965, 2020 12.
Article em En | MEDLINE | ID: mdl-32552363
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Recidivante-Remitente / Esclerose Múltipla Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Recidivante-Remitente / Esclerose Múltipla Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article